Related Experiment Video
Updated: May 17, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Prognostic Effect of pan-Immune-Inflammation Value Indices in Patients with Acute Coronary Syndrome Undergoing
Yan Liu1, Xinchen Wang1, Ge Song1
1Department of Cardiology, The Affiliated Hospital of Chengde Medical University, Chengde, China.
Insights
Higher pan-immune-inflammation values (PIV), PIV/HDL-C, and PIV*LDL-C predict major adverse cardiovascular events (MACEs) in acute coronary syndrome (ACS) patients after percutaneous coronary intervention (PCI). These markers may serve as novel biomarkers for predicting MACEs in this population.
Area of Science:
- Cardiology
- Biomarkers
- Inflammation
Background:
- Acute coronary syndrome (ACS) poses significant cardiovascular risk.
- Percutaneous coronary intervention (PCI) is a common treatment for ACS.
- Prognostic markers are crucial for managing ACS patients undergoing PCI.
Purpose of the Study:
- To investigate the association of pan-immune-inflammation value (PIV) and its ratios (PIV/HDL-C, PIV*LDL-C) with prognosis in ACS patients undergoing PCI.
- To identify novel biomarkers for predicting major adverse cardiovascular events (MACEs) in this patient group.
Main Methods:
- A cohort of 1360 ACS patients undergoing PCI was analyzed.
- Patients were categorized into MACEs and non-MACEs groups.
- PIV, PIV/HDL-C, and PIV*LDL-C values were measured and correlated with MACEs outcomes.
Main Results:
- Elevated PIV (≥355.79), PIV/HDL-C (≥282.86), and PIV*LDL-C (≥1431.58) were identified as independent predictors of MACEs.
- Multivariable Cox regression analysis confirmed these associations (all P < .05).
- Patients with higher index values exhibited significantly lower cumulative survival rates (log-rank tests, P < .05).
Conclusions:
- Higher PIV, PIV/HDL-C, and PIV*LDL-C are independent prognostic factors for ACS patients undergoing PCI.
- These inflammatory indices may serve as novel biomarkers for predicting MACEs.
- The findings highlight the role of systemic inflammation in ACS prognosis post-PCI.
Abstract:
BackgroundThis study aimed to investigate the association of pan-immune-inflammation value (PIV), PIV/HDL-C (high-density lipoprotein cholesterol), PIV*LDL-C (low-density lipoprotein cholesterol) with the prognosis of patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI).MethodsA total of 1360 patients with ACS undergoing PCI were consecutively enrolled in this study. They were divided into major adverse cardiovascular events (MACEs) (n = 58) and non-MACEs (n = 1302) groups. The PIV, PIV/HDL-C, and PIV*LDL-C values were measured. The endpoints were MACEs, including cardiogenic mortality, recurrence of myocardial infarction, in-stent restenosis, and rehospitalization for severe heart failure.ResultsThe multivariable Cox regression analysis showed that PIV ≥355.79 (hazard ratio [HR]: 2.006, 95% confidence interval [CI]: 1.165-3.455), PIV/HDL-C ≥ 282.86 (HR: 1.987, 95% CI: 1.119-3.527), and PIV*LDL-C ≥ 1431.58 (HR: 2.071, 95% CI: 1.206-3.556) were all independent predictors of MACEs in patients with ACS undergoing PCI (all P < .05). The cumulative survival rates were significantly lower for patients with higher PIV, PIV/HDL-C, and PIV*LDL-C than for patients with lower values of these indices (log-rank tests: all P < .05).ConclusionHigher PIV, PIV/HDL-C, and PIV*LDL-C were independent prognostic factors for patients with ACS undergoing PCI and may be novel biomarkers for predicting MACEs.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Pancreatitis II: Clinical Manifestations and Management
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...